Life Science Nutritionals Launches Adult Essentials Gummies with MEG-3® Omega-3 EPA/DHA

Ocean Nutrition Canada Limited (ONC), the world’s largest Omega-3 EPA/DHA solutions provider and supplier of MEG-3® brand Omega-3 EPA/DHA ingredients, is pleased to announce the launch of Adult Essentials Gummies Omega-3 and Enhanced Multivitamin, both with Omega-3 EPA/DHA. These two new Omega-3-containing adult gummies are a part of Life Science Nutritionals’ new line of all natural gummy vitamins formulated for adults – the first of its kind in Canada.

Nova Scotia Students Win Big in Top-Talent Scholarship Program, the Halifax-based student professional social network, announced today the winners in its Top-Talent Scholarship program.

Top-Talent Scholarships are distributed to high school and university/college students and are awarded based on academic achievement and community participation.

"Equals6 is dedicated to supporting students in their academic and career pursuits," said Andy Osburn, president and CEO of "I want to congratulate all the scholarship winners and wish them the best of luck in their studies."

NSCC, Innovacorp Foster Start-up Businesses in Western Valley

Nova Scotia Community College and Innovacorp are teaming up to support potential geomatics, IT and clean technology businesses in the western Annapolis Valley.

The Strategic Alliance Agreement, signed Tuesday, June 28, by Innovacorp president and CEO Clifford Gross and NSCC president Don Bureaux, will help attract emerging companies to the business incubation space at NSCC's Annapolis Valley Campus in Middleton.

Cycle Capital Management Concludes an Investment in Nova Scotia

Cycle Capital Management Inc. today (June 21, 2011) announced a $4-million financial contribution of Cycle Capital Fund LP in LED Roadway Lighting Ltd. (LRL), a Nova Scotia designer and manufacturer of LED-based street and area lighting. This investment is part of a total round of $8 million and is made in collaboration with Nova Scotia Business Inc. (NSBI), the province's private-sector-led business development agency.

FDA Approves Immunovaccine’s Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine

Immunovaccine Inc. (TSX-V: IMV), announced today that the US Food and Drug Administration (FDA) reviewed and cleared its Investigational New Drug (IND) application for a Phase I/II clinical study with DPX-Survivac, a therapeutic cancer vaccine. DPX-Survivac will be tested in patients with ovarian cancer.

New Brunswick to Contribute to Regional Venture Capital Fund

Regional co-operation in Atlantic Canada took another step forward today, June 5, as New Brunswick joined Nova Scotia in a regional venture capital fund to support emerging companies in the region.

New Brunswick will contribute $15 million to fund, created by Nova Scotia and announced in April. Companies involved in clean technology, life sciences, information technology and other high-growth sectors will be able to access the fund.


Subscribe to Innovacorp RSS